Milla L. Kuusisto
Oulu, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Early venetoclax dose escalation at minimal residual disease progression may benefit selected acute myeloid leukaemia patients.
Journal: British journal of haematology
Published: March 05, 2026
The Impact of the BCR Phenotype of Large B-cell Lymphoma on Ibrutinib Sensitivity.
Journal: Anticancer research
Published: March 01, 2026
Incidence and Mortality of Mycosis Fungoides and Sezary Syndrome: A Nationwide Registry Study in Finland.
Journal: Acta dermato-venereologica
Published: June 30, 2025
Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation.
Journal: European journal of haematology
Published: June 28, 2025
Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma.
Journal: Cancer medicine
Published: March 17, 2025
Oxidative stress markers 8-OHdG, Trx-1, and Prx6 are expressed in seminoma and are connected to TXNDC2, 3, and 6 expression levels.
Journal: Histology and histopathology
Published: March 17, 2025
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial.
Journal: Basic & clinical pharmacology & toxicology
Published: November 18, 2024
DLBCL cells with ferroptosis morphology can be detected with a deep convolutional neural network.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 14, 2024
Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients.
Journal: European journal of haematology
Published: September 19, 2024
Last Updated: 09/26/2026